NCT04869631View on ClinicalTrials.gov

Screening for Amyloidosis Before Aortic Valve Elective Replacement

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2028

Conditions
AmyloidosisAortic Valve Stenosis
Interventions
OTHER

The outcome of an intervention is not evaluated, but aortic stenosis and additional amyloidosis are compared.

We aim to compare patients with aortic valve stenosis with and without cardiac amyloidosis.

Trial Locations (1)

10117

Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors
collaborator

Deutsches Herzzentrum Berlin, Klinik für Innere Medizin - Kardiologie

UNKNOWN

collaborator

Klinik für Neurologie mit Experimenteller Neurologie, Charité - Universitätsmedizin Berlin

UNKNOWN

lead

Charite University, Berlin, Germany

OTHER